Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Developing Nutrient Enriched Perfusate for Ex Vivo Lung Perfusion

EF 2021-22

Résumé
Lung transplantation is the only curative intervention for end stage lung disease. Unfortunately, transplantation procedures are limited by low organ utilization rates. Ex Vivo Lung Perfusion (EVLP) is a technology that restores organ metabolism by maintaining lungs at 37°C though a circulating perfusate and mechanical ventilation, thus allowing clinicians to repair donor lungs which would have been discarded. Extending EVLP support time can further increase organ utilization and has been achieved with total parental nutrition (TPN) supplemented perfusates. However, the specific nutritional components supporting lung metabolism and the role of other protective nutrients (GlutaMAX, lipids, and carbohydrates) in EVLP remains unknown. We hypothesize that optimized compositions and concentrations of nutrients (TPN, GlutaMAX, lipids, and Glucose) will address metabolic demands of lung cells to maintain cellular metabolism and physiological function during extended EVLP. Mathematical modeling using clinical nutrient concentrations and infusion rates will be coupled with a dilution factor to estimate nutrient accumulation during EVLP. Using these models, low, medium, and high concentrated nutrient supplemented perfusates will be developed. A screening stage will then evaluate cell confluence, death, and migration of pulmonary endothelial cells exposed to diverse nutrient supplemented perfusates. Solutions which perform significantly better than the standard perfusate (Steen) will be tested in an EVLP culture model with the addition of lung epithelial cells to evaluate inflammation, cell structure, and mitochondrial health. Overall, we can use our results to develop the next generation of EVLP perfusates and significantly improve transplant patient outcomes.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466938
Name
Bojic Dejan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Developing Nutrient Enriched Perfusate for Ex Vivo Lung Perfusion
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Ex Vivo Lung Perfusion; Glutamax; Intralipid; Perfusate; Total Paternal Nutrition
Abstract
Lung transplantation is the only curative intervention for end stage lung disease. Unfortunately, transplantation procedures are limited by low organ utilization rates. Ex Vivo Lung Perfusion (EVLP) is a technology that restores organ metabolism by maintaining lungs at 37°C though a circulating perfusate and mechanical ventilation, thus allowing clinicians to repair donor lungs which would have been discarded. Extending EVLP support time can further increase organ utilization and has been achieved with total parental nutrition (TPN) supplemented perfusates. However, the specific nutritional components supporting lung metabolism and the role of other protective nutrients (GlutaMAX, lipids, and carbohydrates) in EVLP remains unknown. We hypothesize that optimized compositions and concentrations of nutrients (TPN, GlutaMAX, lipids, and Glucose) will address metabolic demands of lung cells to maintain cellular metabolism and physiological function during extended EVLP. Mathematical modeling using clinical nutrient concentrations and infusion rates will be coupled with a dilution factor to estimate nutrient accumulation during EVLP. Using these models, low, medium, and high concentrated nutrient supplemented perfusates will be developed. A screening stage will then evaluate cell confluence, death, and migration of pulmonary endothelial cells exposed to diverse nutrient supplemented perfusates. Solutions which perform significantly better than the standard perfusate (Steen) will be tested in an EVLP culture model with the addition of lung epithelial cells to evaluate inflammation, cell structure, and mitochondrial health. Overall, we can use our results to develop the next generation of EVLP perfusates and significantly improve transplant patient outcomes.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bojic, Dejan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~